| Teratology |
| Wendy Chung, MD PhD |
| Teratology |
| The study of abnormal development in embryos and the causes of congenital malformations or birth defects |
| Birth Defects |
| Observed in 3% of newborns | |
| Observed in another 3% of children later | |
| May or may not be outwardly visible | |
| Etiology: genetic and environmental |
| Slide 4 |
| Major and Minor Anomalies |
| Major anomalies: life/health threatening | |
| Minor anomalies: cosmetic | |
| The greater the number of minor anomalies, the greater the likelihood of a major anomaly | |
| Certain minor anomalies suggest specific major anomalies |
| Down Syndrome |
| Turner Syndrome |
| Trisomy 13 |
| Midline defects (cleft lip and cleft palate) | |
| Central nervous system malformations | |
| Micro-ophthalmia | |
| Congenital heart disease | |
| Poor growth |
| Trisomy 18 |
| Achondroplasia |
| Inborn Errors of Metabolism Causing Birth Defects |
| Smith Lemli Opitz | |
| Congenital disorders of glycosylation | |
| Fatty acid oxidation disorders |
| Teratogens |
| A chemical, infectious agent, physical condition, or deficiency that, on fetal exposure, can alter fetal morphology or subsequent function | |
| Teratogenicity depends upon the ability of the agent to cross the placenta | |
| The embryo is most susceptible to teratogenic agents during periods of rapid differentiation |
| Slide 13 |
| Slide 14 |
| How are agents determined to be teratogenic ? |
| Anecdotal data in humans | |
| Data from animal studies |
| Effect of Exposure Depends on Timing |
| All or none effect early | |
| Effect of organogenesis during embryonic development | |
| Effect on size and function during fetal development |
| Slide 17 |
| Nicotine |
| IUGR | |
| Premature delivery | |
| Neurocognitive development |
| Fetal Alcohol Syndrome |
| Characteristic facial features | |
| Congenital heart disease | |
| Growth deficiency | |
| Behavioral/neurocognitive deficits |
| Fetal Alcohol Syndrome |
| Tetraclycine |
| Yellow/brown teeth | |
| Decreased bone growth |
| Fetal Hydantoin Syndrome |
| Intrauterine growth retardation | |
| Microcephaly, mental retardation | |
| Distal phalangeal hypoplasia | |
| Specific facial features |
| Retinoic acid |
| Craniofacial dysmorphisms | |
| Cleft palate | |
| Thymic aplasia | |
| Neural tube defects |
| Thalidomide Syndrome |
| Congenital Rubella |
| Congenital CMV |
| Intrauterine growth retardation | |
| Micromelia | |
| Chorioretinitis, blindness | |
| Microcephaly | |
| Cerebral calcifications, mental retardation | |
| Hepatosplenomegaly |
| Ionizing Radiation |
| Affects brain development at 10-18 weeks of gestation a HIGH dose | |
| No evidence of effect of exposure associated with typical diagnostic studies |
| Maternal Hyperglycemia |
| Congenital heart disease | |
| Renal, gastrointestinal, and central nervous system malformations such as neural tube defects |
| Babies of Mother’s with PKU |
| Mental retardation | |
| Low birth weight | |
| Congenital heart diseas |
| Slide 30 |
| Threshold Effect-Multifactorial |